Skip to main content
Log in

Synthesis and hemodynamic effects of a new endothelin-converting enzyme inhibitor

  • Biophysics and Biochemistry
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Abstract

A new endothelin-converting enzyme inhibitor PP-35 including Nα-benzylsuccinyl group and Leu-Trp-OH dipeptide is synthesized. Similarly to phosphoramidon substance PP-35 abolishes elevation of systemic blood pressure and heart rate decrease in normotensive rats in response to bolus injection of big endothelin-1. Hemodynamic responses to endothelin-1 remain unchanged.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. O. A. Gomazkov, V. F. Pozdnev, E. V. Kalinina,et al., Byull. Eksp. Biol. Med.,122, No. 9, 279–281 (1996).

    CAS  Google Scholar 

  2. E. V. Kalinina, V. F. Pozdnev, N. V. Komissarova, and O. A. Gomazkov,Biokhimiya,62, No. 3, 247–250 (1997).

    CAS  Google Scholar 

  3. K. Barnes, K. Shimada, M. Takahashi,et al., J. Cell. Sci.,109, 919–928 (1996).

    PubMed  CAS  Google Scholar 

  4. R. Bihovsky, B. Levinson, R. Loewi,et al., J. Med. Chem.,38, 2119–2129 (1995).

    Article  PubMed  CAS  Google Scholar 

  5. R. Corder and J. Vane,Biochem. Pharmacol.,49, 375–380 (1995).

    Article  PubMed  CAS  Google Scholar 

  6. P. Deprez, J. Guillaume, J. Dumas, and J.-P., Vevert,Bioorg. Med. Chem. Lett.,6, 2317–2322 (1996).

    Article  CAS  Google Scholar 

  7. P. Dispaquale, L. Valdes, V. Albano,et al., J. Cardiovasc. Pharmacol.,29, 202–208 (1997).

    Article  Google Scholar 

  8. S. Galatiusjensen, H. Wroblewski, C. Emmeluth,et al., Cardiovasc. Res.,32, 1148–1154 (1996).

    Article  CAS  Google Scholar 

  9. G. Gray and D. Webb,Pharmacol. Ther. 72, 109–148 (1996).

    Article  PubMed  CAS  Google Scholar 

  10. P. Kukkola, N. Bilci, W. Kozak,et al., Bioorg. Med. Chem. Lett.,6, 619–624 (1996).

    Article  CAS  Google Scholar 

  11. A. Morita, M. Nomizu, M. Okitsu,et al., FEBS Lett.,353, 84–88 (1994).

    Article  PubMed  CAS  Google Scholar 

  12. A. Patil, A. Freyer, D. Eggleston,et al., J. Nat. Prod.,60, 306–308 (1997).

    Article  PubMed  CAS  Google Scholar 

  13. R. Rhoten, Y. Comair, D. Shedid,et al., J. Neurosurg.,86, 101–108 (1997).

    Article  PubMed  CAS  Google Scholar 

  14. Y. Tsurumi, H. Uede, K. Hayashi,et al., J. Antibiot. (Tokyo), 48, 1066–1075 (1995).

    CAS  Google Scholar 

  15. A. Turner and L. Murphy,Biochem. Pharmacol.,51, 91–102 (1996).

    Article  PubMed  CAS  Google Scholar 

  16. M. Yangisawa, H. Kurihara, S. Kimura,et al., Nature,332, 411–415 (1988).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 126, No. 11, pp. 526–529, November, 1998

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pozdnev, V.F., Gomazkov, O.A., Davydova, M.P. et al. Synthesis and hemodynamic effects of a new endothelin-converting enzyme inhibitor. Bull Exp Biol Med 126, 1110–1112 (1998). https://doi.org/10.1007/BF02447247

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02447247

Key Words

Navigation